Rebirthel Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 10

Rebirthel General Information

Description

Developer of cellular immunotherapies intended to provide medical care for autoimmune diseases and cancer. The company generates innovative cell therapy by controlling the immune system by returning regulatory cells and activating them in vitro, enabling patients to get an effective treatment method.

Contact Information

Website
www.rebirthel.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 311, Creation Core Kyoto Mikuruma
  • 448-5 Kajii-cho, Kamigyo-ku
  • Kyoto, 602-0841
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Room 311, Creation Core Kyoto Mikuruma
  • 448-5 Kajii-cho, Kamigyo-ku
  • Kyoto, 602-0841
  • Japan

Rebirthel Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rebirthel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator 26-Jul-2023 Completed Pre-Clinical Trials
8. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
7. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
6. Early Stage VC (Series A) 01-Dec-2022 Completed Pre-Clinical Trials
5. Accelerator/Incubator 01-Oct-2022 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Jan-2022 Completed Pre-Clinical Trials
3. Early Stage VC Completed Pre-Clinical Trials
2. Seed Round 17-Dec-2020 $33.2K $33.2K Completed Pre-Clinical Trials
1. Spin-Off 01-Oct-2019 Completed Startup
To view Rebirthel’s complete valuation and funding history, request access »

Rebirthel Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class C Preferred Shares
Class B Preferred Shares
Class A Preferred Shares 1,570,000 $0.02 $0.02 1x $0.02 21.7%
To view Rebirthel’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Rebirthel Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rebirthel Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Osaka Innovation Hub Accelerator/Incubator Minority
Beyond Japan Accelerator/Incubator
Institute for the Global Entrepreneur Accelerator/Incubator
Chushin Venture Capital Corporate Venture Capital Minority
Healthcare Innovation Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Rebirthel FAQs

  • When was Rebirthel founded?

    Rebirthel was founded in 2019.

  • Where is Rebirthel headquartered?

    Rebirthel is headquartered in Kyoto, Japan.

  • What is the size of Rebirthel?

    Rebirthel has 2 total employees.

  • What industry is Rebirthel in?

    Rebirthel’s primary industry is Drug Discovery.

  • Is Rebirthel a private or public company?

    Rebirthel is a Private company.

  • What is Rebirthel’s current revenue?

    The current revenue for Rebirthel is .

  • How much funding has Rebirthel raised over time?

    Rebirthel has raised $2.58M.

  • Who are Rebirthel’s investors?

    Osaka Innovation Hub, Beyond Japan, Institute for the Global Entrepreneur, Chushin Venture Capital, and Healthcare Innovation are 5 of 10 investors who have invested in Rebirthel.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process